| Income Statement | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Total other (expense) income net | 235,850 | 354,864 | ||
| Net loss | -10,091,496 | -9,866,442 | ||
| Loss per common share basic (in dollars per share) | -0.3 | -0.3 | ||
| Loss per common share diluted (in dollars per share) | -0.3 | -0.3 | ||
| Weighted average number of common shares outstanding basic (in shares) | 33,191,622 | 33,191,622 | ||
| Weighted average number of common shares outstanding diluted (in shares) | 33,191,622 | 33,191,622 | ||
RELMADA THERAPEUTICS, INC. (RLMD)
RELMADA THERAPEUTICS, INC. (RLMD)